Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate versus Tocilizumab for Treatment of Giant Cell Arteritis
2018-002826-22Phase 3Active
- Sponsor
- Centre Hospitalier Universitaire Dijon Bourgogne
- Start
- Nov 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in giant cell arteritis (GCA) comparing Methotrexate arm with Tocilizumab arm (2 arms). Started Nov 2018; status: active.
02
Drugs
methotrexatetocilizumab
03
Conditions
giant cell arteritis (GCA)
Beyond the preview
Go deeper on 2018-002826-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002826-22.